Esther Rajavelu is CFO & CBO of Spero Therapeutics, Inc.. Currently has a direct ownership of 724,720 shares of SPRO, which is worth approximately $601,517. The most recent transaction as insider was on Feb 05, 2025, when has been sold 20,689 shares (Common Stock) at a price of $0.78 per share, resulting in proceeds of $16,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 725K
91.08% 3M change
72.61% 12M change
Total Value Held $601,517

Esther Rajavelu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2025
SELL
Open market or private sale
$16,137 $0.78 p/Share
20,689 Reduced 2.78%
724,720 Common Stock
Feb 03 2025
BUY
Grant, award, or other acquisition
-
366,139 Added 32.94%
745,409 Common Stock
Nov 08 2024
SELL
Open market or private sale
$22,418 $1.3 p/Share
17,245 Reduced 4.35%
379,270 Common Stock
Nov 07 2024
SELL
Open market or private sale
$30,589 $1.31 p/Share
23,351 Reduced 5.56%
396,515 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
119,866 Added 22.21%
419,866 Common Stock
Nov 13 2023
BUY
Grant, award, or other acquisition
-
300,000 Added 50.0%
300,000 Common Stock

Also insider at

FULC
Fulcrum Therapeutics, Inc. Healthcare
ER

Esther Rajavelu

CFO & CBO
Cambridge, MA

Track Institutional and Insider Activities on SPRO

Follow Spero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if
Any

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Spero Therapeutics, Inc.

Track Activities on SPRO